Empire State Ride Raises Over $11 Million for Cancer Research at Roswell Park Comprehensive Cancer Center

Strategic Insights -

Over 200 cyclists from across the country participated in the 7-day Empire State Ride from July 26 to August 2, raising funds for cancer research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. The event has become a significant movement in the fight against cancer, with its inaugural ride in 2024 raising over $11 million for critical research and clinical trials. This substantial amount of funding has enabled Roswell Park to launch new research programs and advance promising initiatives, including the development of a first-of-its-kind brain cancer vaccine, SurVaxM, and the Roswell Park Liquid Biopsy, an innovative blood test for cancer treatment.

Key Takeaways:

  • Empire State Ride is a 7-day bicycling event that raises funds for cancer research at Roswell Park Comprehensive Cancer Center, with over 200 participants from across the country.
  • The event has raised over $11 million since its inaugural ride in 2024, enabling Roswell Park to launch new research programs and advance promising initiatives.
  • The funds raised will support research programs such as the SurVaxM brain cancer vaccine and the Roswell Park Liquid Biopsy, an innovative blood test for cancer treatment.
  • The event has become a significant movement in the fight against cancer, with riders committed to raising at least $3,500 for cutting-edge research at Roswell Park.
  • Empire State Ride participants ride through some of the most scenic parts of New York State, including Staten Island, New York City, and Niagara Falls.
  • The funds raised through the Empire State Ride enable Roswell Park to launch new research programs and advance some of its most promising initiatives.

Statistics:

  • Over 200 cyclists participated in the 7-day Empire State Ride from July 26 to August 2.
  • The event has raised over $11 million since its inaugural ride in 2024.
  • Riders were committed to raising at least $3,500 for cutting-edge research at Roswell Park Comprehensive Cancer Center.
  • The event has become a significant movement in the fight against cancer, with a worldwide impact.
  • The FDA granted Fast-Track Designation to SurVaxM in early 2024, providing more extensive and accelerated access to FDA resources for the development of the novel cancer trial.
  • The FDA expanded orphan drug status designation for SurVaxM to broaden the vaccine's potential use from adult glioblastoma to any malignant glioma in children or adults.

Sources:

  • Empire State Ride press release, Buffalo, New York, July 24
  • EmpireStateRide.com
  • About Roswell Park press release
  • Roswell Park Comprehensive Cancer Center website
  • National Cancer Institute website
  • FDA website